CPG10101 Combination Therapy For The Treatment Of Hepatitis C In Relapsed Hepatitis C Virus (HCV) Subjects

Clinical trial NCT00142103 · COMPLETED

Trial details

NCT number: NCT00142103
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatitis, Chronic Active

Start date: 2005-09-01
Primary completion: 2007-02-01
Enrollment: 91

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.